- Home
- SHIP vs ACHV Comparison
SHIP vs ACHV Comparison
Compare SHIP & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- ACHV
- Stock Information
- Founded
- SHIP 2008
- ACHV N/A
- Country
- SHIP Greece
- ACHV United States
- Employees
- SHIP N/A
- ACHV N/A
- Industry
- SHIP Marine Transportation
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SHIP Consumer Discretionary
- ACHV Health Care
- Exchange
- SHIP Nasdaq
- ACHV Nasdaq
- Market Cap
- SHIP 127.6M
- ACHV 131.2M
- IPO Year
- SHIP 2007
- ACHV N/A
- Fundamental
- Price
- SHIP $7.14
- ACHV $2.68
- Analyst Decision
- SHIP Strong Buy
- ACHV Strong Buy
- Analyst Count
- SHIP 1
- ACHV 3
- Target Price
- SHIP $11.00
- ACHV $14.33
- AVG Volume (30 Days)
- SHIP 124.2K
- ACHV 2.0M
- Earning Date
- SHIP 08-05-2025
- ACHV 08-07-2025
- Dividend Yield
- SHIP 10.64%
- ACHV N/A
- EPS Growth
- SHIP 48.17
- ACHV N/A
- EPS
- SHIP 1.26
- ACHV N/A
- Revenue
- SHIP $153,372,000.00
- ACHV N/A
- Revenue This Year
- SHIP N/A
- ACHV N/A
- Revenue Next Year
- SHIP $21.78
- ACHV N/A
- P/E Ratio
- SHIP $5.65
- ACHV N/A
- Revenue Growth
- SHIP 17.53
- ACHV N/A
- 52 Week Low
- SHIP $4.78
- ACHV $1.84
- 52 Week High
- SHIP $12.65
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- SHIP 60.56
- ACHV 48.14
- Support Level
- SHIP $6.97
- ACHV $2.58
- Resistance Level
- SHIP $7.35
- ACHV $2.77
- Average True Range (ATR)
- SHIP 0.25
- ACHV 0.18
- MACD
- SHIP 0.05
- ACHV 0.05
- Stochastic Oscillator
- SHIP 79.61
- ACHV 78.48
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship, among others.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.